Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
The optimal antithrombotic treatment in patients receiving oral anticoagulation undergoing percutaneous coronary intervention (PCI) has been a field of intensive research. Although triple antithrombotic therapy had been, until lately, the strategy of choice, recent evidence points to the superiority...
Saved in:
| Main Authors: | Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos, Dimitrios Alexopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-05-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.31 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021-10-01) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021-06-01) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020-11-01) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021-05-01) -
ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)